Navigation Links
Ultrasound plus proteomic blood analyses may help physicians diagnose early-stage ovarian cancer
Date:1/21/2010

imaging technique called contrast-enhanced ultrasound may play a complementary role to confirming or refuting newly discovered biomarkers' ability to accurately detect early-stage ovarian cancer. "We also found that the contrast agents may significantly improve the diagnostic ability of ultrasound to identify early microvascular changes that are known to be associated with early-stage ovarian cancer," said Arthur C. Fleischer, MD, co-author of the article.

"Separately, proteomics and ultrasound are of limited value as early-detection tools," said Fleischer. "However in combination, we will likely be able to shift from an era of diagnosing advanced stage ovarian cancer to that of early-stage disease and, most important, save the lives of many women," he said.


'/>"/>

Contact: Heather Curry
hcurry@acr-arrs.org
703-390-9822
American College of Radiology / American Roentgen Ray Society
Source:Eurekalert

Page: 1 2

Related medicine news :

1. New acoustic absorber to improve physiotherapy ultrasound machines
2. Ultrasound plus mammography finds more cancers, but increases false positives
3. Good Imaging Now Comes in the Worlds Smallest Ultrasound Package
4. VIDEO from Medialink and Siemens: Worlds Smallest Ultrasound Package Launches in the U.S.
5. Aloka to Unveil New ProSound Diagnostic Ultrasound System at the 17th World Congress on Ultrasound in Obstetrics and Gynecology, 7th to 11th of October 2007 in Florence, Italy
6. Transcutaneous cervical esophageal ultrasound can not substitute for 24-h pH monitoring or manometry
7. Ultrasound-guided injections help ease chronic Achilles tendon pain
8. Ultrasound Beats Blood Test for Gauging Ovarian Cancers: Study
9. Through-Wave Ultrasound: Effective, Economical and Ideal for Breast Imaging, Biopsy
10. ZONARE Surpasses 1000th Worldwide z.one Ultrasound System Shipment
11. Ultrasound Treats Localized Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... July 31, 2015 , ... Ticket Down is a reliable source for ... Chicago at Grant Park. The festival will end on Sunday, August 2nd. ... for the annual Lollapalooza. This unique and unbelievably popular festival attracts the best ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... The 2nd ... Church Park in Downtown Memphis on October 3, 2015. The Ride to Fight On ... on cancer research between Methodist Healthcare, The West Clinic and The University of Tennessee ...
(Date:7/31/2015)... ... July 31, 2015 , ... Facebook, Twitter, Linkedin and ... their social media profiles to better connect with the public. The agency website ... information, share insights and opinions. The Rally Insurance Group, Inc.’s pledge to provide ...
(Date:7/31/2015)... ... ... article published July 27 on My News LA, a fire that broke out ... fire department before it caused major damage throughout the building. The article also notes that ... a fire alarm system that tipped off fire fighters so they could arrive at the ...
(Date:7/31/2015)... ... July 31, 2015 , ... Cosmetic ... potential patients alike on various plastic surgery procedures including, but not limited to, ... popular dermatology procedures like Botox and fillers. , Staying up to date ...
Breaking Medicine News(10 mins):Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3Health News:Rally Insurance Group, Inc. Connects to Customers Through Re-branded Social Media Profiles 2Health News:Article on Recent Pasadena Courtroom Fire Highlights the Effectiveness of Fire Alarm Systems, Says Fire Protection Group Inc 2Health News:Article on Recent Pasadena Courtroom Fire Highlights the Effectiveness of Fire Alarm Systems, Says Fire Protection Group Inc 3Health News:Cosmetic Town: Now Providing Interactive And Vital Medical Knowledge 2
... Amira Pharmaceuticals, Inc., a small molecule pharmaceutical company focused ... to treat inflammatory disease, announced today that Robert Baltera, ... the Montgomery Healthcare Conference 2009 in Menlo Park, Calif., ... 2005 and headquartered in San Diego, Amira Pharmaceuticals is ...
... NEW YORK, Oct. 6 TechCrunch50 2009 Finalist Glide ... announced today a partnership to deploy the Glide Health ... group practice in the United States, with over 100 ... million patients. , Glide Health is the complete ...
... Research Center, Group Health Research Institute and the ... Pharmacy have been selected to lead four projects ... funding for comparative-effectiveness research in cancer. The grants ... such research, which aims to objectively analyze cancer ...
... (SRS) and whole brain radiation therapy (WBRT) for the treatment ... of developing learning and memory problems than those treated with ... M. D. Anderson Cancer Center. The findings of the ... 2009 online edition of the Lancet Oncology . Led ...
... San Diego, CA Nearly all patients who underwent ... obstructive sleep apnea (OSA), according to new research presented ... Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO, in ... collected data from 22 patients treated for oropharyngeal cancer, ...
... used for applications that include inventory management, package ... security. More recently, these systems have found their ... assets and staff members. However, there is ... manufacturers of RFID equipment or medical devices can ...
Cached Medicine News:Health News:Glide Health Corporation and Integrated Medical Professionals Announce Partnership to Deploy the Glide Mobile Health Platform to Over One Million Patients and Over 100 Physicians in 50 Locations 2Health News:$16M in stimulus funding launches Seattle as a hub of comparative-effectiveness research in cancer 2Health News:$16M in stimulus funding launches Seattle as a hub of comparative-effectiveness research in cancer 3Health News:$16M in stimulus funding launches Seattle as a hub of comparative-effectiveness research in cancer 4Health News:$16M in stimulus funding launches Seattle as a hub of comparative-effectiveness research in cancer 5Health News:Stereotactic radiosurgery preferred method of treating cancer patients with brain metastases 2Health News:Stereotactic radiosurgery preferred method of treating cancer patients with brain metastases 3Health News:GTRI is developing protocols for testing effects of RFID systems on medical devices 2Health News:GTRI is developing protocols for testing effects of RFID systems on medical devices 3
(Date:7/30/2015)... Mettler-Toledo International Inc. (NYSE: MTD ) ... are the highlights: , Sales in local ... prior year. Reported sales decreased 4% as currency reduced ... Net earnings per diluted share as reported (EPS) were ... EPS was $2.80 , an increase of 9% ...
(Date:7/30/2015)... DIEGO , July 30, 2015  Tandem ... medical device company and manufacturer of the t:slim® ... has entered into non-exclusive Development Agreements with Dexcom, ... Tandem insulin pumps with the Dexcom G5 and ... "Integrating Tandem,s next generation pump platform with Dexcom,s ...
(Date:7/30/2015)... Wash. and VANCOUVER , ... OGXI ) announced today that it will report its ... 2015. Company management will host a conference call and ... an overview of financial results, clinical development programs and ... the webcast, log on to the Investor Relations page ...
Breaking Medicine Technology:Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 14Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3
... MAY 22, 2012 ThermoGenesis Corp. (NASDAQ: ... the processing, storage and administration of cell therapies, today ... its AXP® AutoXpress® Platform (AXP) used for the processing ... initiate commercial activities in the country later this year. ...
... Holdings, Inc., the tenth largest workers, compensation insurer ... from Medco Health Solutions to Express Scripts as their ... analytics capabilities and insights generated by its team of ... waste and help improve outcomes for injured workers ...
Cached Medicine Technology:ThermoGenesis Announces Axp Approval In Thailand 2ThermoGenesis Announces Axp Approval In Thailand 3Accident Fund Holdings Aims to Improve Control of Drug Utilization and Quality of Care with Change in Pharmacy Benefit Manager 2
Liquichek Whole Blood Volatiles Control is an assayed liquid control for monitoring volatile compounds. This product is available in 2 levels....
qUAntify Plus Control is a combination urine dipstick and microscopic control. The control is available in either 12 mL centrifuge tubes or 120 mL flip-top squeeze bottles....
Lyphochek Tumor Marker Control is a comprehensive, bilevel product designed to assess the performance of various cancer antigen tests, including esoteric tumor markers....
Lyphochek Hypertension Markers Control is a trilevel control designed to monitor the performance of testing procedures for renin and other analytes associated with hypertension disorders....
Medicine Products: